0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      O-027BEACON CRC study safety lead-in: Assessment of the BRAF inhibitor encorafenib + MEK inhibitor binimetinib + anti–epidermal growth factor receptor antibody cetuximab for BRAFV600E metastatic colorectal cancer

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Author and article information

          Journal
          Annals of Oncology
          Oxford University Press (OUP)
          0923-7534
          1569-8041
          June 2018
          June 01 2018
          June 20 2018
          June 2018
          June 01 2018
          June 20 2018
          : 29
          : suppl_5
          Affiliations
          [1 ]University Hospitals Gasthuisberg Leuven and KU Leuven, Leuven, Belgium
          [2 ]Imelda Ziekenhuis, Bonheiden, Belgium
          [3 ]Netherlands Cancer Institute, Amsterdam, Netherlands
          [4 ]The Netherlands Cancer Institute, Amsterdam, Netherlands
          [5 ]Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
          [6 ]Memorial Sloan-Kettering Cancer Center, New York, New York, USA
          [7 ]City of Hope, Duarte, California, USA
          [8 ]Department of Medical Oncology, Hospital Universitari del Mar, Barcelona, Spain
          [9 ]Department of Oncology, Antwerp University Hospital, Edegem, Belgium
          [10 ]Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Walter and Eliza Hall Institute, Parkville, Australia
          [11 ]National Cancer Center Hospital East, Kashiwa, Japan
          [12 ]University of Campania, Naples, Italy
          [13 ]Hammersmith Hospital, Department of Cancer Medicine, London, UK
          [14 ]Array BioPharma Inc., Boulder, Colorado, USA
          [15 ]UT MD Anderson Cancer Center, Houston, Texas, USA
          [16 ]Mayo Clinic, Rochester, Minnesota, USA
          [17 ]Vall d’Hebron University Hospital and Vall d’Hebron Institute of Oncology, Barcelona, Spain
          Article
          10.1093/annonc/mdy149.026
          313f35f3-f9ba-4400-adaf-6aecbf36110b
          © 2018

          https://academic.oup.com/journals/pages/about_us/legal/notices

          History

          Comments

          Comment on this article